RAC 2.80% $1.57 race oncology ltd

Because the orally administrated Venetoclax was released 3 years...

  1. 2,589 Posts.
    lightbulb Created with Sketch. 3163
    Because the orally administrated Venetoclax was released 3 years ago and is now dominating the market.

    Zan synergises with Venetoclax (preclinically) but who is going to want to sit in a chair for hours on end every day to receive it when they can take the SOC at home and knock it back with a shandy?
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.57
Change
-0.045(2.80%)
Mkt cap ! $260.3M
Open High Low Value Volume
$1.60 $1.60 $1.55 $94.33K 60.12K

Buyers (Bids)

No. Vol. Price($)
1 1250 $1.57
 

Sellers (Offers)

Price($) Vol. No.
$1.59 5000 1
View Market Depth
Last trade - 14.37pm 16/05/2024 (20 minute delay) ?
Last
$1.56
  Change
-0.045 ( 1.17 %)
Open High Low Volume
$1.58 $1.59 $1.55 8174
Last updated 14.21pm 16/05/2024 ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.